# Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State

> **NCT07342062** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DA-1229_01
- **DRUG:** DA-1229_01-R

## Key facts

- **NCT ID:** NCT07342062
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-06
- **Primary completion:** 2026-02-14
- **Final completion:** 2026-02-14
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342062, "Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07342062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*